Kevin M Crombie1, Anneliis Sartin-Tarm2, Kyrie Sellnow2, Rachel Ahrenholtz2, Sierra Lee2, Megan Matalamaki2, Neda E Almassi3, Cecilia J Hillard4, Kelli F Koltyn3, Tom G Adams5, Josh M Cisler6. 1. University of Wisconsin, Department of Psychiatry, 6001 Research Park Boulevard, Madison, WI 53719-1176, United States. Electronic address: kmcrombie@wisc.edu. 2. University of Wisconsin, Department of Psychiatry, 6001 Research Park Boulevard, Madison, WI 53719-1176, United States. 3. University of Wisconsin, Department of Kinesiology, 285 Med Sci, 1300 University Ave, Madison, WI 53706-1121, United States. 4. Medical College of Wisconsin, Neuroscience Research Center, Department of Pharmacology and Toxicology, 8701 Watertown Plank Rd., Milwaukee, WI 53226, United States. 5. University of Kentucky, Department of Psychology, 105 Kastle Hill, Lexington, KY 40506-0044, United States; Yale School of Medicine, Department of Psychiatry, 300 George St., New Haven, CT 06511, United States; National Center for PTSD, Clinical Neurosciences Division, VA CT Healthcare System, 950 Campbell Avenue, West Haven, CT 06516, United States. 6. University of Texas at Austin, Department of Psychiatry and Behavioral Sciences, 1601 Trinity St, Bldg B, Austin, TX 78712, United States.
Abstract
INTRODUCTION: We recently demonstrated that moderate-intensity aerobic exercise delivered during the consolidation of fear extinction learning reduced threat expectancy during a test of extinction recall among women with posttraumatic stress disorder (PTSD). These findings suggest that exercise may be a potential candidate for improving the efficacy of exposure-based therapies, which are hypothesized to work via the mechanisms of fear extinction learning. The purpose of this secondary analysis was to examine whether exercise-induced increases in circulating concentrations of candidate biomarkers: endocannabinoids (anandamide [AEA]; 2-arachidonoylglycerol [2-AG], brain-derived neurotrophic factor (BDNF), and homovanillic acid (HVA), mediate the effects of exercise on extinction recall. METHODS: Participants (N = 35) completed a 3-day fear acquisition (day 1), extinction (day 2), and extinction recall (day 3) protocol, in which participants were randomly assigned to complete either moderate-intensity aerobic exercise (EX) or a light-intensity control (CON) condition following extinction training (day 2). Blood was obtained prior to and following EX or CON. Threat expectancy ratings during tests of extinction recall (i.e., initial fear recall and fear recall following reinstatement) were obtained 24 h following EX or CON. Mediation was tested using linear-mixed effects models and bootstrapping of the indirect effect. RESULTS: Circulating concentrations of AEA and BDNF (but not 2-AG and HVA) were found to mediate the relationship between moderate-intensity aerobic exercise and reduced threat expectancy ratings following reinstatement (AEA 95% CI: -0.623 to -0.005; BDNF 95% CI: -0.941 to -0.005). CONCLUSIONS: Exercise-induced increases in peripheral AEA and BDNF appear to play a role in enhancing consolidation of fear extinction learning, thereby leading to reduced threat expectancies following reinstatement among women with PTSD. Future mechanistic research examining these and other biomarkers (e.g., brain-based biomarkers) is warranted.
INTRODUCTION: We recently demonstrated that moderate-intensity aerobic exercise delivered during the consolidation of fear extinction learning reduced threat expectancy during a test of extinction recall among women with posttraumatic stress disorder (PTSD). These findings suggest that exercise may be a potential candidate for improving the efficacy of exposure-based therapies, which are hypothesized to work via the mechanisms of fear extinction learning. The purpose of this secondary analysis was to examine whether exercise-induced increases in circulating concentrations of candidate biomarkers: endocannabinoids (anandamide [AEA]; 2-arachidonoylglycerol [2-AG], brain-derived neurotrophic factor (BDNF), and homovanillic acid (HVA), mediate the effects of exercise on extinction recall. METHODS: Participants (N = 35) completed a 3-day fear acquisition (day 1), extinction (day 2), and extinction recall (day 3) protocol, in which participants were randomly assigned to complete either moderate-intensity aerobic exercise (EX) or a light-intensity control (CON) condition following extinction training (day 2). Blood was obtained prior to and following EX or CON. Threat expectancy ratings during tests of extinction recall (i.e., initial fear recall and fear recall following reinstatement) were obtained 24 h following EX or CON. Mediation was tested using linear-mixed effects models and bootstrapping of the indirect effect. RESULTS: Circulating concentrations of AEA and BDNF (but not 2-AG and HVA) were found to mediate the relationship between moderate-intensity aerobic exercise and reduced threat expectancy ratings following reinstatement (AEA 95% CI: -0.623 to -0.005; BDNF 95% CI: -0.941 to -0.005). CONCLUSIONS: Exercise-induced increases in peripheral AEA and BDNF appear to play a role in enhancing consolidation of fear extinction learning, thereby leading to reduced threat expectancies following reinstatement among women with PTSD. Future mechanistic research examining these and other biomarkers (e.g., brain-based biomarkers) is warranted.
Authors: Leah M Mayo; Anna Asratian; Johan Lindé; Lovisa Holm; Daniel Nätt; Gaëlle Augier; Niclas Stensson; Haley A Vecchiarelli; Georgia Balsevich; Robert J Aukema; Bijar Ghafouri; Primavera A Spagnolo; Francis S Lee; Matthew N Hill; Markus Heilig Journal: Mol Psychiatry Date: 2018-08-17 Impact factor: 15.992
Authors: Mark B Powers; Johnna L Medina; Stephanie Burns; Brooke Y Kauffman; Marie Monfils; Gordon J G Asmundson; Allison Diamond; Christa McIntyre; Jasper A J Smits Journal: Cogn Behav Ther Date: 2015-02-23
Authors: Jacob D Meyer; Kelli F Koltyn; Aaron J Stegner; Jee-Seon Kim; Dane B Cook Journal: Psychoneuroendocrinology Date: 2016-09-28 Impact factor: 4.905
Authors: Shreya Desai; Breanna Borg; Carrie Cuttler; Kevin M Crombie; Christine A Rabinak; Matthew N Hill; Hilary A Marusak Journal: Cannabis Cannabinoid Res Date: 2021-12-03